Lijie Huang

Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Retraction Note: Tumour microenvironment programming by an RNA-RNA-binding protein complex creates a druggable vulnerability in IDH-wild-type glioblastoma.

Retraction Note: Tumour microenvironment programming by an RNA-RNA-binding protein complex creates a druggable vulnerability in IDH-wild-type glioblastoma.

Journal: Nature cell biology

Published: January 17, 2025

Neuron-like lineage differentiation induced by exogenous Neurexin-1 as a potential therapeutic strategy for glioma.

Neuron-like lineage differentiation induced by exogenous Neurexin-1 as a potential therapeutic strategy for glioma.

Journal: Cancer letters

Published: February 08, 2024

PVT1 promotes proliferation and macrophage immunosuppressive polarization through STAT1 and CX3CL1 regulation in glioblastoma multiforme.

PVT1 promotes proliferation and macrophage immunosuppressive polarization through STAT1 and CX3CL1 regulation in glioblastoma multiforme.

Journal: CNS neuroscience & therapeutics

Published: September 15, 2023

Tumour microenvironment programming by an RNA-RNA-binding protein complex creates a druggable vulnerability in IDH-wild-type glioblastoma.

Tumour microenvironment programming by an RNA-RNA-binding protein complex creates a druggable vulnerability in IDH-wild-type glioblastoma.

Journal: Nature cell biology

Published: March 21, 2023

FXYD2 mRNA expression represents a new independent factor that affects survival of glioma patients and predicts chemosensitivity of patients to temozolomide.

FXYD2 mRNA expression represents a new independent factor that affects survival of glioma patients and predicts chemosensitivity of patients to temozolomide.

Journal: BMC neurology

Published: June 30, 2021

A potentially effective drug for patients with recurrent glioma: sermorelin.

A potentially effective drug for patients with recurrent glioma: sermorelin.

Journal: Annals of translational medicine

Published: April 12, 2021

High-sensitive clinical diagnostic method for PTPRZ1-MET and the characteristic protein structure contributing to ligand-independent MET activation.

High-sensitive clinical diagnostic method for PTPRZ1-MET and the characteristic protein structure contributing to ligand-independent MET activation.

Journal: CNS neuroscience & therapeutics

Published: September 13, 2020

Redox Regulator GLRX Is Associated With Tumor Immunity in Glioma.

Redox Regulator GLRX Is Associated With Tumor Immunity in Glioma.

Journal: Frontiers in immunology

Published: July 07, 2020

ABCC8 mRNA expression is an independent prognostic factor for glioma and can predict chemosensitivity.

ABCC8 mRNA expression is an independent prognostic factor for glioma and can predict chemosensitivity.

Journal: Scientific reports

Published: May 07, 2020

ASPM promotes glioblastoma growth by regulating G1 restriction point progression and Wnt-β-catenin signaling.

ASPM promotes glioblastoma growth by regulating G1 restriction point progression and Wnt-β-catenin signaling.

Journal: Aging

Published: August 11, 2019

EFEMP2 indicates assembly of M0 macrophage and more malignant phenotypes of glioma.

EFEMP2 indicates assembly of M0 macrophage and more malignant phenotypes of glioma.

Journal: Aging

Published: April 27, 2019

Identification of survival‑associated key genes and long non‑coding RNAs in glioblastoma multiforme by weighted gene co‑expression network analysis.

Identification of survival‑associated key genes and long non‑coding RNAs in glioblastoma multiforme by weighted gene co‑expression network analysis.

Journal: International journal of molecular medicine

Published: September 28, 2018

Showing 1-12 of 13

Last Updated: 09/26/2026